FOI.ICB-2526/457: PMDD Diagnosis Waiting Times 文件类型 PDF 文件大小 248 KB 29 4 月 2026 FOI.ICB-2526/457: PMDD Diagnosis Waiting Times
FOI.ICB-2526/454: Funding, Commissioning Pathways, and IFR Data for Dissociative Identity Disorder (DID) & Dissociative Disorders 文件类型 PDF 文件大小 696 KB 29 4 月 2026 FOI.ICB-2526/454: Funding, Commissioning Pathways, and IFR Data for Dissociative Identity Disorder (DID) & Dissociative Disorders
FOI.ICB-2627/001: Use of AI-powered medical scribe or transcription software in patient consultations 文件类型 PDF 文件大小 271 KB 28 4 月 2026 FOI.ICB-2627/001: Use of AI-powered medical scribe or transcription software in patient consultations
FOI.ICB-2627/034: Public Email List of Dispensing Doctors 文件类型 PDF 文件大小 242 KB 27 4 月 2026 FOI.ICB-2627/034: Public Email List of Dispensing Doctors
FOI.ICB-2627/009: Dissociative Disorder IFRs and Service Commissioning 文件类型 PDF 文件大小 271 KB 27 4 月 2026 FOI.ICB-2627/009: Dissociative Disorder IFRs and Service Commissioning
FOI.ICB-2527/005: Recorded Assurance for Software Based Data Erasure of End of Life IT Equipment 文件类型 PDF 文件大小 253 KB 24 4 月 2026 FOI.ICB-2527/005: Recorded Assurance for Software Based Data Erasure of End of Life IT Equipment
FOI.ICB-2425/335: Frenchay Community Hospital 文件类型 PDF 文件大小 1 MB 23 4 月 2026 FOI.ICB-2425/335: Frenchay Community Hospital
FOI.ICB-2425/346: Rehabilitation Facilities at Frenchay Hospital Site 文件类型 PDF 文件大小 1 MB 23 4 月 2026 FOI.ICB-2425/346: Rehabilitation Facilities at Frenchay Hospital Site
FOI.ICB-2526/458: Virtual, Telephone and Face-to-Face Consultation Services 文件类型 PDF 文件大小 302 KB 22 4 月 2026 FOI.ICB-2526/458: Virtual, Telephone and Face-to-Face Consultation Services
FOI.ICB-2526/449: Supported living and residential care services for adults with Learning Disabilities (LD) 文件类型 PDF 文件大小 392 KB 22 4 月 2026 FOI.ICB-2526/449: Supported living and residential care services for adults with Learning Disabilities (LD)
FOI.ICB-2627/002: Eligibility Criteria for Injectable Weight Loss Medication 文件类型 PDF 文件大小 499 KB 22 4 月 2026 FOI.ICB-2627/002: Eligibility Criteria for Injectable Weight Loss Medication